Vous n'êtes pas identifié (connexion)

Centre de recherche

VENDREDI 24 MARS

Prof. Taha B. M. J. Ouarda

Conférence

Modèles statistiques en épidémiologie

Calendrier >

BOTTIN

Eric Wagner

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
R-00-750
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 48291
Télécopieur(s)
+1 418-654-2765
Courriel(s)
Eric.Wagner@chuq.qc.ca

Publications récentes (voir toutes les publications de ce chercheur)

Beland MA, Lapointe I, Noel R, Cote I, Wagner E, Riopel J, Latulippe E, Desy O, Beland S, Magee CN, Houde I, De Serres SA. Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study. Transplant international : official journal of the European Society for Organ Transplantation,  2017. Epub
Jean M, Raghavan A, Charles ML, Robbins MS, Wagner E, Rivard GE, Charest-Morin X, Marceau F. The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents. Life sciences,  2016. 155: 180-8
Susal C, Dohler B, Ruhenstroth A, Morath C, Slavcev A, Fehr T, Wagner E, Kruger B, Rees M, Balen S, Zivcic-Cosic S, Norman DJ, Kuypers D, Emonds MP, Pisarski P, Bosmuller C, Weimer R, Mytilineos J, Scherer S, Tran TH, Gombos P, Schemmer P, Zeier M, Opelz G, Collaborative Transplant Study Report. Donor-specific antibodies require preactivated immune system to harm renal transplant. EBioMedicine,  2016. 9: 366-71
Merlen C, Bonnefoy A, Wagner E, Dedeken L, Leclerc JM, Laverdiere C, Rivard GE. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia. Pediatric blood & cancer,  2015. 62: 1381-7
Lesage J, Noel R, Lapointe I, Cote I, Wagner E, Desy O, Caumartin Y, Agharazii M, Batal I, Houde I, De Serres SA. Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy. Transplantation,  2015. 99: 69-76
Susal C, Wettstein D, Dohler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Zivcic-Cosic S, Balen S, Weimer R, Slavcev A, Bosmuller C, Norman DJ, Zeier M, Opelz G, A Collaborative Transplant Study Report. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation,  2015. 99: 1976-80
De Serres SA, Noel R, Cote I, Lapointe I, Wagner E, Riopel J, Latulippe E, Agharazii M, Houde I. 2013 Banff Criteria for Chronic Active Antibody-Mediated Rejection: Assessment in a Real Life Setting. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,  2015. Epub
Vallin P, Desy O, Beland S, Wagner E, De Serres SA. Clinical relevance of circulating antibodies and B lymphocyte markers in allograft rejection. Clinical biochemistry,  2015. Epub
Levy J, Rivard GE, Wagner E, Beezhold D, Berlin N, Fan L, Zhang Z, Sussman GL. Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema. Allergy, asthma, and clinical immunology : official journal of the Canadian,  2014. 10: 60
Wagner E, Frank MM. Therapeutic potential of complement modulation. Nature reviews. Drug discovery,  2010. 9: 43-56
© 2017 Tous droits réservés Centre de recherche du CHU de Québec